Hepatitis A and B are the most common vaccine-preventable diseases for travelers; nevertheless, up to 50% of confirmed cases of hepatitis A and B in Europe are still acquired during travel.

Adults typically receive the hepatitis B vaccine in a two- or three-dose series. Engerix-B is also offered as a four-dose series for adults who are undergoing hemodialysis (kidney dialysis).

His fourth and current book serves as a tribute to the many accomplishments of Maurice Hilleman and is based on a series ... first cancer vaccines (for Marek's disease and hepatitis B), the ...

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results for the fourth ...